Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of autologous, heterologous, and umbilical cord serum eye drops for severe dry eye syndrome
2012-001556-19Phase 2Active
- Sponsor
- Fundación IMABIS
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous serum artificial tears and human umbilical cord blood serum in dry eye syndrome (DED) (3 arms), sponsored by Fundación IMABIS. Started May 2012; status: active.
02
Drugs
autologous serum artificial tearshuman umbilical cord blood serum
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2012-001556-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001556-19.